BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Endothelial cell
,
DNA fingerprint
,
Cisplatin
,
rs2300478
,
SNCA
,
Apoptosis
,
Arthritis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
target of rapamycin
Summary
General Info
Curated Studies
Most Correlated Studies
CD4+ T cells treated with rapamycin or halofuginone during Th17 polarization
CD4 T-cells with MTOR, ZAP70 silencing, or treated with Rapamycin or Cyclosporin A
T cells (CD4+ CD25-) pretreated with or without rapamycin and stimulated with anti-CD3/CD28
CD8+ T cells specific for Ova peptide SIINFEKL treated with rapamycin and anti-CTLA4 post activation
CD8+ T cells resistant or sensitive to cyclosporine
Explore Curated Studies Results
Literature
Most Relevant Literature
Evaluation of Akt and RICTOR Expression Levels in Astrocytomas of All Grades.
Tor1 and CK2 kinases control a switch between alternative ribosome biogenesis pathways in a growth-d…
mTOR has distinct functions in generating versus sustaining humoral immunity.
Aspirin disrupts the mTOR-Raptor complex and potentiates the anti-cancer activities of sorafenib via…
Statistical evaluation of DPPH, ABTS, FRAP, and Folin-Ciocalteu assays to assess the antioxidant cap…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Impacts of Mechanistic Target of Rapamycin (mTOR) Inhibition on Aged Human Muscle (Rapamune)
TARGET-PREMIER Trail in Evaluating the Safety and Efficacy of the Rapamycin Target Eluting Stent in …
Efficacy and Safety of the Mammalian Target of Rapamycin (mTor Rapamycin) Inhibitor in Vascular Malf…
Effect of the Inhibition of the Mammalian Target of Rapamycin on Metabolism and Exercise
Dietary Protein and Monocyte/Macrophage Mammalian Target of Rapamycin (mTOR) Signaling
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ